您的位置: 首页 > 农业专利 > 详情页

Tumorspecific SPECT/MR(T1), SPECT/MR(T2) and SPECT/CT contrast agents
专利权人:
János BORBÉLY
发明人:
János BORBÉLY,István HAJDU,Magdolna BODNÁR,Zsuzsanna CSIKÓS
申请号:
US14133975
公开号:
US20150004096A1
申请日:
2013.12.19
申请国别(地区):
US
年份:
2015
代理人:
摘要:
The invention relates to cancer receptor-specific bioprobes for single photon emission computed tomography (SPECT) and computed tomography (CT) or magnetic resonance imaging (MRI) for dual modality molecular imaging. The base of the bioprobes is the self-assembled polyelectrolytes, which transport gold nanoparticles as CT contrast agents, or SPION or Gd(III) ions as MR active ligands, and are labeled using complexing agent with technetium-99m as SPECT radiopharmacon. Furthermore these dual modality SPECT/CT and SPECT/MR contrast agents are labeled with targeting moieties to realize the tumorspecificity.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充